ASPI vs BWXT
ASPI: An advanced materials company commercializing proprietary isotope enrichment technologies for nuclear medicine, semiconductors, and small modular reactors, combined with LNG and helium production through its Renergen subsidiary. BWXT: BWX Technologies is a critical provider of nuclear reactors, fuel, and components for the U.S. Navy and the commercial nuclear power industry, supported by over a century of specialized nuclear engineering expertise.
Side-by-side fundamentals
| Metric | ASPI | BWXT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $4.08 | $175.17 | |
| Market cap as of 2026-07-23 | $514M | $16.0B | |
| P/E as of 2026-07-23 | n/a | 46.39 | |
| PEG as of 2026-07-23 | -0.01 | 4.34 | ASPI lower |
| Net margin as of 2026-07-23 | -644.4% | +10.2% | BWXT higher |
| Gross margin as of 2026-07-23 | +17.6% | +22.7% | BWXT higher |
| Operating margin as of 2026-07-23 | -285.4% | +12.3% | BWXT higher |
| ROE as of 2026-07-23 | -117.2% | +27.9% | BWXT higher |
| ROA as of 2026-07-23 | -47.9% | +8.6% | BWXT higher |
| Debt / equity as of 2026-07-23 | 0.90 | 1.58 | ASPI lower |
| Revenue growth (YoY) as of 2026-07-23 | +511.2% | +21.4% | ASPI higher |
| Revenue CAGR (3y) SEC XBRL | n/a | +12.7% | |
| Dividend yield as of 2026-07-23 | n/a | +0.6% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 3.73 | 0.76 | |
| 1-year return as of 2026-07-22 close | -56.2% | +23.3% | BWXT higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.